Back to calendar
Xeris Biopharma Holdings, Inc. (XERS) Earnings
XERS reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.03
Actual EPS: $-0.18
EPS surprise: -1582.34%
Company overview
Market Cap$1.9B
PriceUSD 10.31
EPS (TTM)-0.10
52-week high11.33
52-week low5.25
SectorHealth Technology
IndustryBiotechnology
Employees435